Actively Recruiting
A Study to Evaluate the Efficacy and Safety of AD-218
Led by Addpharma Inc. · Updated on 2025-02-05
520
Participants Needed
1
Research Sites
204 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the efficacy and safety of AD-218
CONDITIONS
Official Title
A Study to Evaluate the Efficacy and Safety of AD-218
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be a man or woman over 19 years old
- Sign the informed consent form before participating in the study
You will not qualify if you...
- History of fibromyalgia or myopathy with creatine kinase levels 2 times or more above the upper limit of normal
- Other unspecified exclusion criteria applied
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Yeongnam University Hospital
Daegu, Nam-gu, South Korea, 42415
Actively Recruiting
Research Team
S
Sarah Yoon
CONTACT
K
Kyu Chang Won, M.D., Ph.D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here